Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 27186434PMCID PMC4859887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

  2016cited by this paper
• Genotype/Phenotype Correlations in Patients with Hereditary Breast Cancer

  2015cited by this paper
• Envisioning the dynamics and flexibility of Mre11-Rad50-Nbs1 complex to decipher its roles in DNA replication and repair.

  2015cited by this paper
• Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases

  2015influential reference
• Arsenic Inhibits DNA Mismatch Repair by Promoting EGFR Expression and PCNA Phosphorylation*

  2015influential reference
• Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy

  2015cited by this paper
• Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers

  2015cited by this paper
• Regulators of homologous recombination repair as novel targets for cancer treatment

  2015influential reference
• Mismatch Repair Deficiency Testing for Patients with Colorectal Cancer: A Clinical and Cost-Effectiveness Evaluation

  2015cited by this paper
• An update on PARP inhibitors for the treatment of cancer

  2015cited by this paper
• Olaparib in the management of ovarian cancer

  2015cited by this paper
• Poly (ADP-ribose) polymerase inhibitors: recent advances and future development.

  2015influential reference
• Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis

  2015influential reference
• Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response

  2015influential reference
• BRCA1 Mutation: A Predictive Marker for Radiation Therapy?

  2015cited by this paper
• Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes

  2015cited by this paper
• DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities.

  2014cited by this paper
• 'BRCAness' and its implications for platinum action in gynecologic cancer.

  2014cited by this paper
• EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4.

  2014influential reference
• Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response.

  2014cited by this paper
• The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer

  2014cited by this paper
• Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer

  2014cited by this paper
• Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

  2014influential reference
• The Multifunctional Protein Kinase C-ε in Cancer Development and Progression

  2014cited by this paper
• Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy.

  2014cited by this paper
• PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies.

  2014cited by this paper
• Modernizing the nonhomologous end-joining repertoire: alternative and classical NHEJ share the stage.

  2013influential reference
• Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides

  2013cited by this paper
• The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D)

  2013cited by this paper
• Base excision repair.

  2013cited by this paper
• The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects

  2013cited by this paper
• Biological consequences of radiation-induced DNA damage: relevance to radiotherapy.

  2013influential reference
• Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.

  2013cited by this paper
• Canonical RTK-Ras-ERK signaling and related alternative pathways

  2013cited by this paper
• Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation.

  2013cited by this paper
• Treatment of Triple-Negative Breast Cancer Using Anti-EGFR–Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor

  2013cited by this paper
• APEX Nuclease (Multifunctional DNA Repair Enzyme) 1 Gene Asp148Glu Polymorphism and Cancer Risk: A Meta-Analysis Involving 58 Articles and 48903 Participants

  2013cited by this paper
• Resistance to PARP-Inhibitors in Cancer Therapy

  2013cited by this paper
• DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology.

  2013cited by this paper
• Ovarian Cancer - A Clinical and Translational Update

  2013cited by this paper
• Proteome-wide identification of poly(ADP-Ribosyl)ation targets in different genotoxic stress responses.

  2013cited by this paper
• Nuclear EGFR Suppresses Ribonuclease Activity of Polynucleotide Phosphorylase through DNAPK-mediated Phosphorylation at Serine 776*

  2012cited by this paper
• Membrane-bound Trafficking Regulates Nuclear Transport of Integral Epidermal Growth Factor Receptor (EGFR) and ErbB-2*

  2012cited by this paper
• Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells

  2012cited by this paper
• RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites

  2012cited by this paper
• Association between Single Nucleotide Polymorphisms in ERCC4 and Risk of Squamous Cell Carcinoma of the Head and Neck

  2012cited by this paper
• Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability

  2012cited by this paper
• Poly(ADP-ribose) Contributes to an Association between Poly(ADP-ribose) Polymerase-1 and Xeroderma Pigmentosum Complementation Group A in Nucleotide Excision Repair*

  2012cited by this paper
• The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.

  2011cited by this paper
• Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells*

  2011cited by this paper
• A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells

  2011cited by this paper
• Genetic Variants of XRCC1, APE1, and ADPRT Genes and Risk of Bladder Cancer

  2010cited by this paper
• Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2

  2010cited by this paper
• Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes

  2010cited by this paper
• DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome

  2010cited by this paper
• Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.

  2010cited by this paper
• The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

  2010cited by this paper
• Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate

  2010cited by this paper
• Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control.

  2009cited by this paper
• Principles of cancer therapy: oncogene and non-oncogene addiction.

  2009cited by this paper
• Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport.

  2009cited by this paper
• Targeting the RAF-MEK-ERK pathway in cancer therapy.

  2009cited by this paper
• The DNA-damage response in human biology and disease

  2009cited by this paper
• Mechanistic flexibility as a conserved theme across 3 billion years of nonhomologous DNA end-joining.

  2008cited by this paper
• Homologous recombination in DNA repair and DNA damage tolerance

  2008influential reference
• The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.

  2008cited by this paper
• XRCC1 polymorphism and lung cancer risk

  2008cited by this paper
• Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

  2008cited by this paper
• Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression

  2008cited by this paper
• PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.

  2008cited by this paper
• Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation.

  2008cited by this paper
• HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells.

  2008cited by this paper
• The Epidermal Growth Factor Receptor: A Role in Repair of Radiation-Induced DNA Damage

  2007cited by this paper
• The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells

  2007influential reference
• Genetic polymorphisms in DNA base‐excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck

  2007cited by this paper
• The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation.

  2007cited by this paper
• Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases.

  2007cited by this paper
• HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination

  2007cited by this paper
• Tyrosine phosphorylation controls PCNA function through protein stability

  2006influential reference
• A conserved RAS/mitogen-activated protein kinase pathway regulates DNA damage-induced cell death postirradiation in Radelegans.

  2006cited by this paper
• DNA Repair and Mutagenesis

  2006influential reference
• Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.

  2006cited by this paper
• Co‐regulation of B‐Myb expression by E2F1 and EGF receptor

  2006cited by this paper
• Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase*

  2005cited by this paper
• [Base excision repair].

  2005influential reference
• Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway.

  2005cited by this paper
• Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

  2005cited by this paper
• Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity.

  2005cited by this paper
• The PARP superfamily

  2004cited by this paper
• G1 and S-phase checkpoints, chromosome instability, and cancer.

  2004cited by this paper
• Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

  2003cited by this paper
• Epidermal Growth Factor and Ionizing Radiation Up-regulate the DNA Repair Genes XRCC1 and ERCC1 in DU145 and LNCaP Prostate Carcinoma through MAPK Signaling

  2003cited by this paper
• Clinical biomarkers in drug discovery and development

  2003cited by this paper
• Genetic instability in bladder cancer assessed by the comet assay.

  2003cited by this paper
• Role of DNA mismatch repair defects in the pathogenesis of human cancer.

  2003cited by this paper
• Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer.

  2002cited by this paper
• Polymorphisms in DNA repair genes and associations with cancer risk.

  2002cited by this paper
• Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis.

  2002cited by this paper

• CD146, a therapeutic target involved in cell plasticity

  2024cites this paper
• Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers

  2023cites this paper
• Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma

  2023cites this paper
• Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.

  2023cites this paper
• Characterization and clustering of kinase isoform expression in metastatic melanoma

  2021cites this paper
• Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer.

  2021cites this paper
• NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation.

  2021cites this paper
• Nuclear receptor tyrosine kinase transport and functions in cancer.

  2020cites this paper
• Nuclear Fibroblast Growth Factor Receptor Signaling in Skeletal Development and Disease

  2019cites this paper
• H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism

  2019cites this paper
• Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells.

  2019cites this paper
• Encircling the regions of the pharmacogenomic landscape that determine drug response

  2018cites this paper
• A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases

  2018cites this paper
• RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients

  2018cites this paper
• The cancer cell adhesion resistome: mechanisms, targeting and translational approaches

  2017cites this paper
• PARP inhibitors as precision medicine for cancer treatment

  2017cites this paper
• Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis

  2017cites this paper